ABT vs DOCS
Abbott Laboratories (ABT) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the ABT and DOCS stock pages for the full models.
Not investment advice.